https://scholars.lib.ntu.edu.tw/handle/123456789/593951
標題: | Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD) | 作者: | Shi, Qiang KO-JEN LI Treuer, Tamas Wang, Bruce C M Gaich, Carol L Lee, Chien-Hsun Wu, Wen-Shuo Furnback, Wesley Tang, Chao-Hsiun |
關鍵字: | RISK; PREVALENCE; COMORBIDITY; MANIFESTATIONS; OSTEOPOROSIS; CONSORTIUM; MORTALITY; FREQUENCY; FRACTURE; PEOPLE | 公開日期: | 6-四月-2018 | 出版社: | PUBLIC LIBRARY SCIENCE | 卷: | 13 | 期: | 4 | 起(迄)頁: | e0193489 | 來源出版物: | PloS one | 摘要: | Previous studies in Taiwan utilizing the Taiwan's National Health Insurance Database (NHIRD) have estimated the direct healthcare costs of RA patients, but they have not focused on patients on bDMARDs, or considered patients' response to therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/593951 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0193489 | SDG/關鍵字: | disease modifying antirheumatic drug; glucocorticoid; adalimumab; antirheumatic agent; biological product; etanercept; adult; algorithm; Article; data base; disease burden; female; follow up; health care cost; health care utilization; health economics; human; longitudinal study; major clinical study; male; medication compliance; national health insurance; retrospective study; rheumatoid arthritis; Taiwan; treatment response; cost of illness; economics; factual database; health care cost; insurance; middle aged; public health; rheumatoid arthritis; treatment outcome; very elderly; Adalimumab; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cost of Illness; Databases, Factual; Etanercept; Female; Health Care Costs; Humans; Insurance Claim Review; Male; Middle Aged; National Health Programs; Retrospective Studies; Taiwan; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。